Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory Glaucoma

NAUnknownINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Glaucoma
Interventions
DEVICE

Model iS3 three-stent trabecular micro-bypass system

Provided in Arm/Group descriptions.

Trial Locations (1)

75231

Glaucoma Associates of Tx, Dallas

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY